Dr. Reddys reports consolidated net loss of Rs 538 crore in Q3

27 Jan 2020 Evaluate

Dr. Reddys Laboratories has reported results for third quarter ended December 31, 2019.

The company has reported a rise of 30.62% in its net profit at Rs 521.70 crore for the quarter under review as compared to Rs 399.40 crore for the same quarter in the previous year. Total income of the company increased by 10.22% at Rs 3113.30 crore for Q3FY20 as compared Rs 2,824.50 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a net loss after taxes and share of profit of associates of Rs 538.40 crore for the quarter under review against net profit of Rs 500.30 crore for the same quarter in the previous year. However, total income of the company increased by 12.54% at Rs 4464.40 crore for Q3FY20 as compared Rs 3966.90 crore for the corresponding quarter previous year.

Dr. Reddys Lab Share Price

1175.55 -10.90 (-0.92%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×